JP2010534060A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010534060A5 JP2010534060A5 JP2010516562A JP2010516562A JP2010534060A5 JP 2010534060 A5 JP2010534060 A5 JP 2010534060A5 JP 2010516562 A JP2010516562 A JP 2010516562A JP 2010516562 A JP2010516562 A JP 2010516562A JP 2010534060 A5 JP2010534060 A5 JP 2010534060A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- sequence shown
- nucleic acid
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical group 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 229920001184 polypeptide Polymers 0.000 claims 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 206010056438 Growth hormone deficiency Diseases 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 229940103526 Growth hormone receptor agonist Drugs 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 239000000710 homodimer Substances 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 230000003442 weekly effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95112207P | 2007-07-20 | 2007-07-20 | |
| US60/951,122 | 2007-07-20 | ||
| GBGB0717985.6A GB0717985D0 (en) | 2007-07-20 | 2007-09-14 | Growth hormone fusion proteins |
| GB0717985.6 | 2007-09-14 | ||
| PCT/GB2008/002406 WO2009013461A1 (en) | 2007-07-20 | 2008-07-16 | Growth hormone fusion proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010534060A JP2010534060A (ja) | 2010-11-04 |
| JP2010534060A5 true JP2010534060A5 (enExample) | 2011-09-15 |
| JP5546452B2 JP5546452B2 (ja) | 2014-07-09 |
Family
ID=38658989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010516562A Expired - Fee Related JP5546452B2 (ja) | 2007-07-20 | 2008-07-16 | 成長ホルモン融合タンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8293709B2 (enExample) |
| EP (1) | EP2170943A1 (enExample) |
| JP (1) | JP5546452B2 (enExample) |
| KR (1) | KR20100043201A (enExample) |
| CN (1) | CN101679504B (enExample) |
| AU (1) | AU2008278907B2 (enExample) |
| CA (1) | CA2693951A1 (enExample) |
| GB (1) | GB0717985D0 (enExample) |
| IL (1) | IL202225A (enExample) |
| RU (1) | RU2473554C2 (enExample) |
| WO (1) | WO2009013461A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
| GB0717985D0 (en) * | 2007-07-20 | 2007-10-24 | Asterion Ltd | Growth hormone fusion proteins |
| GB0719818D0 (en) * | 2007-10-11 | 2007-11-21 | Asterion Ltd | Growth hormone fusion polypeptides |
| GB201104285D0 (en) * | 2011-03-15 | 2011-04-27 | Asterion Ltd | Modified receptor fusion proteins |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| US9724396B2 (en) | 2013-03-15 | 2017-08-08 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| GB201316592D0 (en) * | 2013-09-18 | 2013-10-30 | Levicept Ltd | Fusion protein |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| GB201520021D0 (en) | 2015-11-13 | 2015-12-30 | Asterion Ltd | Fusion polypeptide |
| GB201706781D0 (en) | 2017-04-28 | 2017-06-14 | Univ Sheffield | Parathyroid hormone fusion polypeptide |
| EP3930687A4 (en) | 2019-02-25 | 2023-06-07 | The University of Chicago | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS |
| CN113880954B (zh) * | 2021-09-29 | 2024-05-14 | 江苏大学 | 一种重组人生长激素及其构建方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1290170A2 (en) * | 2000-06-16 | 2003-03-12 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
| GB2389115B (en) * | 2001-12-14 | 2005-03-16 | Asterion Ltd | Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone |
| US7625998B2 (en) * | 2003-04-09 | 2009-12-01 | Asterion Limited | Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol |
| US20090221477A1 (en) | 2004-07-26 | 2009-09-03 | Asterion Limited | Linkers |
| GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
| GB0717985D0 (en) * | 2007-07-20 | 2007-10-24 | Asterion Ltd | Growth hormone fusion proteins |
-
2007
- 2007-09-14 GB GBGB0717985.6A patent/GB0717985D0/en not_active Ceased
-
2008
- 2008-07-16 WO PCT/GB2008/002406 patent/WO2009013461A1/en not_active Ceased
- 2008-07-16 JP JP2010516562A patent/JP5546452B2/ja not_active Expired - Fee Related
- 2008-07-16 RU RU2010103157/10A patent/RU2473554C2/ru not_active IP Right Cessation
- 2008-07-16 AU AU2008278907A patent/AU2008278907B2/en not_active Ceased
- 2008-07-16 US US12/669,451 patent/US8293709B2/en not_active Expired - Fee Related
- 2008-07-16 CA CA2693951A patent/CA2693951A1/en not_active Abandoned
- 2008-07-16 EP EP08775945A patent/EP2170943A1/en not_active Withdrawn
- 2008-07-16 CN CN2008800214732A patent/CN101679504B/zh not_active Expired - Fee Related
- 2008-07-16 KR KR1020107002192A patent/KR20100043201A/ko not_active Withdrawn
-
2009
- 2009-11-19 IL IL202225A patent/IL202225A/en not_active IP Right Cessation
-
2012
- 2012-09-14 US US13/620,004 patent/US8470559B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534060A5 (enExample) | ||
| RU2010103157A (ru) | Слитые белки гормона роста | |
| AU2024287134A1 (en) | Multi-chain chimeric polypeptides and uses there | |
| NZ592704A (en) | Lyophilized recombinant von willebrand factor (rVWF) formulation comprising buffering agents, amino acids, stabilising agents and surfactants | |
| NZ597923A (en) | Protein glycosylation | |
| AR069989A1 (es) | Formulaciones de vwf recombinantes | |
| EP2570429A3 (en) | Peptide vaccines with Seq ID No: 48, 41, 44, 46 or 78 for cancers expressing tumor-associated antigens | |
| MY204458A (en) | Tertiary amino lipidated cationic peptides for nucleic acid delivery | |
| US11306296B2 (en) | MG53 mutants, methods of making the same, and uses thereof | |
| JP2004267216A5 (enExample) | ||
| JP2013517781A5 (enExample) | ||
| JP2009527226A5 (enExample) | ||
| NZ604818A (en) | Variants of activin iib receptor polypeptides and uses thereof | |
| JP2010519176A5 (enExample) | ||
| DE60327786D1 (de) | Kdr-peptide und diese enthaltende impfstoffe | |
| NZ621868A (en) | Growth hormone polypeptides and methods of making and using same | |
| JP2018515088A5 (enExample) | ||
| AU2024201860A1 (en) | IL-7Rαγc binding compounds | |
| RU2014122609A (ru) | Модифицированная константная область антитела | |
| JP2013526864A5 (enExample) | ||
| WO2020257639A1 (en) | Multi-chain chimeric polypeptides and uses thereof | |
| JP2003530124A5 (enExample) | ||
| JP2009506753A5 (enExample) | ||
| JP2008510468A5 (enExample) | ||
| EP2481748A3 (en) | Foxp3 peptide vaccine |